Carl Patterson is a seasoned Pharmaceutical Manufacturing, Aseptic Processing, and Quality Assurance professional who is based in San Diego, California. As soon as he discovered the importance of biotechnology in the area, he was inspired to enter the pharmaceutical manufacturing industry. However Read more
This webinar will discuss the regulations pertaining to objectionable microorganisms, agency expectations, methods to identify objectionable microorganisms, interpreting results, and controls to put into place.
Objectionable microorganisms are considered, if discovered, harmful to the patient. By identifying and controlling these microorganism and putting the appropriate controls into place early in the pharmaceutical or medical device manufacturing process, problems in the patient can be prevented.
Course Objectives:
This webinar will review the regulations pertaining to objectionable microorganisms, testing and identifying objectionable microorganisms, and putting appropriate controls into place to prevent harm to the patient. By knowing, where, when, why, and how objectionable microorganisms exist, harmful consequences to the patient can be prevented.
Course Outline:
• Definition of objectionable microorganisms
• Regulations pertaining to objectionable microorganisms
• Identifying objectionable microorganisms
• Tests to determine objectionable microorganisms
• Sources of objectionable microorganisms
• Actions to reduce objectionable microorganism
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• Quality Assurance
• Quality Control
• Production
• Logistics
• Manufacturing
• Quality system auditors
• QA directors and managers
• Microbiology analysts and technicians
• Consultants
• Regulatory and Compliance Management
Training for New Technical Writers
LIVE : Scheduled on
13-January-2025 :01:00 PM EST
|